Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - butorphanol tartrate - solution for injection - 4 milligram(s)/millilitre - butorphanol - cats, dogs - neurological preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - butorphanol tartrate - solution for injection - 4 mg/ml - butorphanol - canine, feline - neurological preparations

United Kingdom - English - VMD (Veterinary Medicines Directorate)

animedica gmbh - butorphanol - solution for injection - neurological agent analgesic - cats, dogs

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - butorphanol tartrate - solution for injection - 10 milligram(s)/millilitre - butorphanol - horses - neurological preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

animedica gmbh - butorphanol tartrate - solution for injection - 10 mg/ml - butorphanol - equine - food - neurological preparations

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

animedica gmbh - butorphanol tartrate 5,83 mg/ml - eq. butorphanol 4 mg/ml - solution for injection - 4 mg/ml - butorphanol tartrate 5.83 mg/ml - butorphanol - dog; cat

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

animedica gmbh - butorphanol tartrate 14,7 mg/ml - eq. butorphanol 10 mg/ml - solution for injection - 10 mg/ml - butorphanol tartrate 14.7 mg/ml - butorphanol - horse

Israel - English - Ministry of Health

eliezer linevitz ltd. - butorphanol as tartrate - solution for injection - butorphanol as tartrate 10 mg / 1 ml - horse:as an analgesic for the short term relief of pain such as colic of gastrointestinal tract origin.as a sedative and pre-anaesthetic in combination with α2-adrenoceptor agonists (detomidine, xylazine);for therapeutic and diagnostic procedures such as minor standing surgery and sedation of intractable patients.dog/cat:as an analgesic for relief of moderate visceral pain e.g. pre- and post-surgical as well as post-traumatic pain.as a sedative in combination with α2-adrenoceptor agonists (medetomidine).as a pre-anaestheticpart of anaesthetic regime (medetomidine, ketamine).

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sildenafil citrate, quantity: 14.05 mg (equivalent: sildenafil, qty 10 mg) - injection, solution - excipient ingredients: glucose monohydrate; water for injections - oral revatio is for the treatment of patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.,revatio solution for injection is for the treatment of adult patients with pulmonary arterial hypertension who are currently prescribed oral revatio and who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.,the efficacy of revatio has not been evaluated in patients currently on bosentan therapy.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - follitropin beta - solution for injection - follitropin beta 833 iu / 1 ml - follitropin beta - follitropin beta - puregon is indicated for the treatment of female infertility in the following clinical situations: anovulation (including polycystic ovarian disease, pcod) in women who have beenunresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)]. in the male : deficient spermatogenesis due to hypogonadotrophic hypogonadism.